Since the beginning of July, The Procter & Gamble Company (NYSE:PG) has consistently risenon the market. The company has gone from $78 per share to $81.40 per share, marking a nearly 4.4% increase in just over a month. The positive momentum is expected to continue, along with good fourth quarter sales results. Let’s take a closer look to see whether or not P&G is a decent bet for investors now.
Organic sales growth in every category with the lowest valuation
The Procter & Gamble Company (NYSE:PG) experienced a decent growth of 2% in its revenue in the fourth quarter, growing from $20.2 billion last year to nearly $20.66 billion this year. The organic sales growth was around 4%, including 2% in net sales growth and 2% in current exchange impact. All five of the company’s business segments (Beauty, Grooming, Healthcare, Fabric Care and Home Care, Baby Care and Family Care) managed to deliver positive organic sales growth in the range of 3% to 7%. The Healthcare segment enjoyed the highest organic sales growth of 7%, including 6% in net sales growth and 2% in foreign exchange impact. It was offset by a negative acquisition and divestiture impact of 1%, however.
Despite the higher sales, The Procter & Gamble Company (NYSE:PG)’s net earnings dropped by as much as 48%, moving from $3.6 billion last year to only $1.88 billion this year. The lower net earnings in the fourth quarter were due to goodwill and intangibles impairment charges of $308 million, as well as an absence of net earnings from discontinued operations. In the fourth quarter of last year, P&G recorded as much as $1.45 billion in profits from discontinued operating earnings. For the full 2013 fiscal year, however, P&G experienced a 5% increase in net profits to more than $11.3 billion or $3.86 per share.
What might drive The Procter & Gamble Company (NYSE:PG)’s operating performance in the future is its current $10 billion cost-saving programs. P&G expects to save around $2 billion in overhead savings and marketing efficiencies, $2 billion in operating leverage, and as much as $6 billion in COGS savings. One of P&G’s biggest shareholders is activist investor Bill Ackman, who thought that the company’s earnings per share could reach $6 in the next three years. Ackman also estimated organic sales growth of 6% and an earnings before interest and taxes (EBIT) margin of 4%. With a simple earnings multiple of 20, P&G should be worth around $125 per share.
At its current trading price of $81.40 per share, The Procter & Gamble Company (NYSE:PG) is worth around $231.25 billion on the market. The market values P&G at nearly 17.4 times its forward earnings. Compared to other consumer giants, including Unilever plc (ADR) (NYSE:UL) and Colgate-Palmolive Company (NYSE:CL), P&G is relatively undervalued.
Unilever with the largest exposure to emerging markets
Unilever plc (ADR) (NYSE:UL) is trading at $41.50 per share, with a total market cap of $117.73 billion. The market values Unilever at 19.1 times its forward earnings. In the first half 2013, Unilever experienced growing operating performance. While the underlying sales increased by 5%, its core earnings per share rose by 4% to €0.76 ($1.01), with free cash flow of around €1.3 ($1.72) billion.
Among the three consumer companies, Unilever has the most exposure to emerging markets, which experienced a 10.3% growth in sales. Unilever derived as much as 55% of its total revenue from emerging markets, while these only accounted for 40% of total P&G revenue.